INCANTHERA
Incanthera Ltd. develops cancer treatment drugs. Its ICT-2588 is a lead compound that is activated within solid tumours by a specific matrix metalloprotease enzyme. The company was incorporated in 2010 and is based in Liverpool, United Kingdom.
INCANTHERA
Industry:
Biopharma Biotechnology Medical
Founded:
2010-01-01
Address:
Liverpool, Liverpool, United Kingdom
Country:
United Kingdom
Website Url:
http://www.incanthera.com
Total Employee:
1+
Status:
Closed
Contact:
441513315220
Total Funding:
650 K GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Universal Analytics Euro Google Maps AJAX Libraries API Google Maps API Microsoft
Similar Organizations
Enterin
Philadelphia-based biotechnology company .
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-01-28 | Spear Therapeutics | Spear Therapeutics acquired by Incanthera | N/A |
| 2014-03-10 | Onco-NX | Onco-NX acquired by Incanthera | N/A |
Investors List
The North West Fund
The North West Fund investment in Venture Round - Incanthera
Official Site Inspections
http://www.incanthera.com Semrush global rank: 6.17 M Semrush visits lastest month: 1.31 K
- Host name: 40.127.234.78
- IP address: 40.127.234.78
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
More informations about "Incanthera"
What we do - incanthera
Incanthera is a UK-based, dermatology and oncology therapeutics company focusing on discovery and development of targeted solutions. The Company has developed sophisticated …See details»
incanthera
Incanthera’s Skincare Range . The Company's current focus is a range of dermatological applications utilising its unique formulation and delivery technologies to meet currently unmet …See details»
Incanthera - Crunchbase Company Profile & Funding
Organization. Incanthera . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Incanthera Ltd. develops cancer treatment …See details»
Corporate Governance - incanthera
Simon is a co-founder of Incanthera and has more than 30 years’ senior experience in academia and business. He was a founder and CEO of Molecular SkinCare Limited, a pioneer and …See details»
Incanthera plc (INC) - Aquis Stock Exchange
Apr 2, 2025 Incanthera is a UK-based, dermatology and oncology therapeutics company focusing on discovery and development of targeted solutions. The Company has developed …See details»
Incanthera plc - LinkedIn
Incanthera plc | 54 followers on LinkedIn. A UK-based, dermatology and oncology therapeutics company focusing on discovery and development of targeted solutions.See details»
Incanthera - Funding, Financials, Valuation & Investors - Crunchbase
Incanthera Ltd. develops cancer treatment drugs. Its ICT-2588 is a lead compound that is activated within solid tumours by a specific. New. Resources. Advanced Search. ... How much …See details»
Incanthera plc (AQU: INC) Company Profile & Overview - Stock …
Oct 31, 2024 Incanthera plc, a dermatology and oncology therapeutics company, focuses on the dermatological formulation and delivery technologies for various indications. It develops …See details»
Incanthera - Contacts, Employees, Board Members, Advisors
Incanthera Ltd. develops cancer treatment drugs. Its ICT-2588 is a lead compound that is activated within solid tumours by a specific ... Pricing. Log In. Log In. Experience the new …See details»
Our strategy - incanthera.com
Identify, Prepare, Commercialise. Our strategy is to identify, prepare and commercialise our portfolio candidates for faster market entry and early revenue generation for the Company, …See details»
Incanthera | VentureRadar
Incanthera is a University of Bradford spin-out and is developing a revolutionary new cancer therapy arising from its Institute of Cancer Therapeutics. The University of Bradford has …See details»
Incanthera 2025 Company Profile: Stock Performance & Earnings
Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and …See details»
Incanthera Ltd - Hardman & Co
Aug 11, 2021 Incanthera is committed to the development of novel treatments for solid tumours (cancers), and licensing these to large pharmaceutical companies. Operating from …See details»
Incanthera Research & Development Ltd. - Drug pipelines, Patents ...
Explore Incanthera Research & Development Ltd. with its drug pipeline, therapeutic area, technology platform, 1 literature, Disease Domain:Neoplasms, Endocrinology ...See details»
Investor and Advisor contacts - incanthera
[email protected] AQSE Exchange Corporate Adviser. Cairn Financial Advisers LLP. 80 Cheapside London EC2V 6EE. Broker. Stanford Capital Partners Limited 2 Leman St, …See details»
Incanthera Company Profile - Office Locations, Competitors ... - Craft
Incanthera is a company that engages in the development of novel treatments for solid tumors (cancers). Its pipeline is oncology-focused, where drug development leverages novel targeting …See details»
Incanthera - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Incanthera uses 9 technology products and services including HTML5, Google Maps API, and jQuery, according to G2 Stack. Incanthera is actively using 25 technologies for its website, …See details»
Results, Reports and Presentations - incanthera
December 18th, 2024 Half-yearly results for the six months ended 30 September 2024See details»
Incanthera | VentureRadar
Incanthera is a University of Bradford spin-out and is developing a revolutionary new cancer therapy arising from its Institute of Cancer Therapeutics. The University of Bradford has …See details»
Incanthera - Research impact - University of Bradford
Incanthera has also acquired the rights to other therapies that target keratosis and melanoma, as well as lung, breast, ovarian, prostate, brain, liver and bladder cancers. Professor Falconer …See details»